BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37728516)

  • 1. Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers.
    Bramblet RM; Bakkum-Gamez JN; Slettedahl SW; Foote PH; Taylor WR; Berger CK; Gysbers BJ; Arndt J; Chen L; Doering KA; Burger KN; Mahoney DW; Sherman ME; Kisiel JB; Samadder NJ
    Cancer Prev Res (Phila); 2023 Nov; 16(11):611-620. PubMed ID: 37728516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
    Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
    Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.
    Canet-Hermida J; Marín F; Dorca E; Dueñas N; Costas L; Salinas M; Velasco À; Peremiquel-Trillas P; Paytubi S; Ponce J; Fernández S; Martínez JM; Cárdenas L; Taltavull A; Alemany L; Meléndez C; Oliveras G; Vidal A; Capellá G; López-Bonet E; Brunet J; Matias-Guiu X; Pineda M
    Mod Pathol; 2023 Jul; 36(7):100158. PubMed ID: 36918055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
    Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
    Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia.
    Ballester V; Taylor WR; Slettedahl SW; Mahoney DW; Yab TC; Sinicrope FA; Boland CR; Lidgard GP; Cruz-Correa MR; Smyrk TC; Boardman LA; Ahlquist DA; Kisiel JB
    Epigenomics; 2020 Dec; 12(24):2173-2187. PubMed ID: 33350853
    [No Abstract]   [Full Text] [Related]  

  • 6. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
    Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
    PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer.
    Takahashi K; Sato N; Sugawara T; Kato A; Sato T; Shimizu D; Tamura D; Kito M; Makino K; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Terada Y
    Gynecol Oncol; 2017 Nov; 147(2):388-395. PubMed ID: 28847642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Adar T; Rodgers LH; Shannon KM; Yoshida M; Ma T; Mattia A; Lauwers GY; Iafrate AJ; Hartford NM; Oliva E; Chung DC
    Cancer; 2018 Aug; 124(15):3145-3153. PubMed ID: 29750335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
    Huang M; Djordjevic B; Yates MS; Urbauer D; Sun C; Burzawa J; Daniels M; Westin SN; Broaddus R; Lu K
    Cancer; 2013 Aug; 119(16):3027-33. PubMed ID: 23760948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
    Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
    Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.
    Wang Y; Wang Y; Li J; Cragun J; Hatch K; Chambers SK; Zheng W
    J Hematol Oncol; 2013 Mar; 6():22. PubMed ID: 23531335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.
    Meyer LA; Broaddus RR; Lu KH
    Cancer Control; 2009 Jan; 16(1):14-22. PubMed ID: 19078925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
    Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
    Front Immunol; 2019; 10():3023. PubMed ID: 31998307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.
    Bruegl AS; Kernberg A; Broaddus RR
    Adv Anat Pathol; 2017 Nov; 24(6):372-378. PubMed ID: 28820751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms and differences in lynch syndrome developing into colorectal cancer and endometrial cancer based on gene expression, methylation, and mutation analysis.
    Li H; Sun L; Zhuang Y; Tian C; Yan F; Zhang Z; Hu Y; Liu P
    Cancer Causes Control; 2022 Apr; 33(4):489-501. PubMed ID: 35149954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current clinical topics of Lynch syndrome.
    Tanakaya K
    Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.